Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA seeks data on BPA-containing devices

This article was originally published in The Gray Sheet

Executive Summary

FDA is requesting information on devices and other medical products that contain the chemical Bisphenol A, whether as part of the product or its packaging, the agency announces Oct. 15. NIH's National Toxicology Program released a draft report in April, finalized Sept. 3, on the potential for BPA to leach from plastics in consumer products and some medical products. After convening an agency-wide taskforce, FDA released a draft assessment Aug. 15 downplaying the toxicity and health risks of BPA in food-contact applications only (1"The Gray Sheet" Aug. 18, 2008, In Brief). But Congressional leaders are investigating a potential conflict of interest because Dr. Martin Philbert, chair of FDA's BPA advisory panel, heads a research center that received a $5 million donation from retired medical equipment manufacturer Charles Gelman, who advocates BPA's safety. Comments on the presence and risks of BPA in devices and other medical products are due Dec. 29
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT026692

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel